Carter Jonas’s Cambridge Planning Team assisted Granta Park Estates in securing planning permission from South Cambridgeshire District Council on the 23rd December 2015 for approximately 55,000m2  (592,015 sqft) of new Research and Development buildings.

This included a full application for a R&D building comprising 21,000m2 earmarked for Illumina, a global leader in genomic analysis and diagnostics, which is now under construction. This will provide a new state-of-the-art building located in scientific research park, Granta Park, and will serve as Illumina’s new European Headquarters. Carter Jonas is continuing to assist during the construction phase of the project.

Carter Jonas has continued to support the evolution of the park over the last 18 months and has since obtained planning consent for a new leisure/amenity building and two significant R&D buildings within the Park for incoming tenants Gilead Sciences Inc. and Heptares Therapeutics Ltd with consent being granted in February 2017.